[What do we know about ATM protein expression in breast tissue?].

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Most breast cancer cases lack high-penetrance mutations (e.g., BRCA1, BRCA2, TP53).
• Low-penetrance genes, common in the general population, may contribute to breast cancer risk.
• The ATM gene, implicated in ataxia telangiectasia, is a potential low-penetrance breast cancer susceptibility gene.

Purpose of the Study:

• To investigate the role of the ATM gene and its protein in breast cancer development.
• To examine ATM protein expression in normal breast tissue, benign lesions, and invasive carcinomas.
• To explore the interplay between ATM and p53 signaling pathways in breast tumors.

Main Methods:

• Immunohistochemical analysis of ATM protein expression in breast tissue samples.
• Evaluation of ATM protein expression in normal ducts, sclerosing adenosis, and invasive carcinomas.
• Assessment of p53 status in conjunction with ATM expression in tumors.

Main Results:

• ATM protein is expressed in epithelial cells of normal breast ducts but not myoepithelial cells.
• In sclerosing adenosis, ATM is expressed in both cell types.
• ATM expression is absent or reduced in 30-50% of invasive breast carcinomas.
• The ATM/p53 signaling pathway is frequently altered in tumors due to low ATM expression or mutated p53.

Conclusions:

• Alterations in ATM gene expression are common in invasive breast carcinomas.
• The ATM/p53 signaling pathway is frequently disrupted in breast cancer.
• Further research is needed to determine if ATM alterations correlate with breast cancer development or radiosensitivity.